1-1 of 1
James R Appleman
Close
Save search
Sort by
Journal Articles

eFT508, a Potent and Selective Mitogen-Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 Inhibitor, Is Efficacious in Preclinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Free
Kevin R. Webster, PhD, Vikas K Goel, PhD, Ivy NJ Hung, PhD, Gregory S Parker, PhD, Jocelyn Staunton, BA, Melissa Neal, Jolene Molter, Gary G Chiang, PhD, Katti A. Jessen, PhD, Christopher J Wegerski, PhD, Samuel Sperry, PhD, Vera Huang, PhD, Joan Chen, PhD, Peggy A Thompson, PhD, James R Appleman, PhD, Stephen E Webber, PhD, Paul A Sprengeler, PhD, Siegfried H Reich, PhD
Journal: Blood
Blood (2015) 126 (23): 1554.
https://doi.org/10.1182/blood.V126.23.1554.1554
Published: 2015